LPU
MDT icon

Lansdowne Partners (UK)’s Medtronic MDT Stock Holding History

Lansdowne Partners (UK)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.95M Hold
88,839
– – 0.29% 20
2026
Q1 		$7.7M Buy
88,839
+57,441
+183% +$5.5M 0.41% 18
2025
Q4 		$3.02M Buy
+31,398
New +$3.05M 0.22% 20

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Lansdowne Partners (UK)'s MDT Position: Q2 2026 in Review

Lansdowne Partners (UK) held its Medtronic (MDT) position steady in Q2 2026 at 88,839 shares worth $6.95M. The position accounts for 0.29% of the portfolio, ranked #20.

Lansdowne Partners (UK) first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.7M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lansdowne Partners (UK) held 88,839 shares of Medtronic worth $6.95M as of Q2 2026.
  • Lansdowne Partners (UK) left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.29% of Lansdowne Partners (UK)'s portfolio in Q2 2026, its #20 holding.
  • Lansdowne Partners (UK) first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Lansdowne Partners (UK)'s Medtronic position peaked at $7.7M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lansdowne Partners (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.